Exploring Precision Oncology: From Gene Fusions to Related Genetic Drivers
Attend this webinar to hear from Dr. Arul Chinnaiyan, molecular pathologist and physician scientist who leads a multi-disciplinary team of investigators at the Michigan Center for Translational Pathology. He and his team work to discover new disease biomarkers and therapeutic targets for cancer diagnosis and treatment using genomics, proteomics, and bioinformatics approaches. The team has also developed a clinical sequencing approach for advanced cancer patients called MIONCOSEQ, which serves as a paradigm for bringing cancer precision medicine to routine clinical care.
This event is part of the Cancer Diagnosis Program Science Session Series. For more information, or if you are an individual with a disability who needs reasonable accommodations to participate in this event, please contact Aniruddha Ganguly, Ph.D., at least 5 business days before the event.
Dr. Chinnaiyan completed both his doctorate and medical degrees, as well as clinical pathology residency, at the University of Michigan. He is a molecular pathologist and physician scientist at the leading edge of translational cancer research and precision oncology.
- NCI Imaging Data Commons Hosts 2022 RSNA Session: Towards Transparency and Reproducibility in Imaging AINovember 27, 2022 - November 30, 2022DataViz + Cancer Micro Lab: Using Data Visualization and Interactive Experiences to Advance Immuno-OncologyDecember 01, 2022